International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Domperidone 5 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2021 - Volume 25, Number 6
View All Articles in Issue

Page(s): 500

Domperidone 5 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Domperidone 5 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: peripherally selective dopamine D2 receptor antagonist, selective D2 blocker, domperidone, oral suspension, formulation, gastroesophageal reflux disease, GERD, upper gastrointestinal motility disorders, dopamine adverse effects, nausea and vomiting, emesis, antiemetic, gastroprokinetic agent, galactagogue

Related Categories: FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Domperidone 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 500
Domperidone 5 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2019 Pg. 316
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Use of Domperidone as a Prokinetic and Antiemetic Albright Lisa M	Mar/Apr 2005 Pg. 120-125 View Sample
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Domperidone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 61
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Phan Ha, DeReese Annie, Day A J, Carvalho Maria	May/Jun 2014 Pg. 203-207
Ranitidine 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2018 Pg. 56
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Famotidine 8-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 382
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 492
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Return to Top